Medsaf

Manage medication purchasing and inventory in one place

Epitaph

“Here lies Medsaf. It connected Nigerian hospitals and pharmacies to verified drug makers to fight counterfeits. When its Series A never closed and its bank line was pulled, the cash ran out, and a last-minute acquisition collapsed before it could refill.”

Overview

Born: 2016 (Year)
Died: March 2025 (Month)
Lifespan: 9 years
Fate: Shut down
Headquarters: 🇳🇬 Nigeria
Category: Health Tech, Logistics & Supply Chain
Stage at death: Seed
Primary cause: Funding or runway
Contributing causes: Business model or unit economics, Acquisition or strategy change, Execution

Death certificate

Timeline

2016Founded
Medsaf founded by Vivian Nwakah and Temitope Awosika to digitize Nigeria's pharmaceutical supply chain
January 2022Funding milestone
Reports $2.7M raised to date including from Y Combinator and Techstars
2022Failed Series A
Series A fundraising attempt unsuccessful
December 2022Salary delays begin
First delayed employee salary payments
2023Bank financing withdrawn
Company loses its bank credit line
March 2023Layoffs
Full-time staff laid off
November 2023Failed acquisition
Potential acquisition deal falls through
March 2024Shutdown communicated
CEO tells investors the company cannot continue

Autopsy report

Why did Medsaf shut down?

Medsaf, a Nigerian pharmaceutical supply-chain platform, ran out of cash after a failed 2022 Series A raise and a withdrawn bank credit line, laid off staff in 2023, and shut down after a late-2023 acquisition attempt fell through, with its CEO telling investors in March 2024 the company could not continue.

What Medsaf attempted

A platform connecting Nigerian hospitals and pharmacies to verified drug manufacturers and distributors to combat counterfeit medication and digitize the pharmaceutical supply chain, including inventory, credit and logistics services.

What worked

Raised over $2 million (reported cumulative figures up to $7M) from investors including Y Combinator, Techstars, and the Bill & Melinda Gates Foundation; built a platform linking hospitals/pharmacies to manufacturers.

Early warning signs

Failed 2022 Series A raise; bank financing withdrawn in 2023; salary payments delayed starting December 2022; unremitted pension/tax contributions; laid off full-time staff in March 2023; lost a major government contract.

What happened

After failing to close a Series A in 2022 and losing bank financing, Medsaf ran low on cash through 2023, laid off staff, attempted an acquisition deal that fell through in November 2023, and the CEO informed investors in March 2024 that the company could not continue, citing the failed acquisition, mounting debts, and unpaid receivables from hospitals.

Lessons for future builders

Working-capital businesses die fast when a single funding source disappears. Do not build operations that assume the next round or credit line will land; keep committed backup financing and enough margin that one withdrawn facility is not fatal.